These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8901002)

  • 1. Effects of MPTP on lever-pressing for light extinction in rats.
    Messaoudi M; Tricoire A; Lalonde R; Canini F; Minn A
    Eur J Pharmacol; 1996 Mar; 299(1-3):17-20. PubMed ID: 8901002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
    Desole MS; Esposito G; Fresu L; Migheli R; Enrico P; Miele M; De Natale G; Miele E
    Neurosci Lett; 1993 Oct; 161(2):121-3. PubMed ID: 7903798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization.
    Shen YQ; Hebert G; Lin LY; Luo YL; Moze E; Li KS; Neveu PJ
    J Neuroimmunol; 2005 Jan; 158(1-2):14-25. PubMed ID: 15589033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
    Oeckl P; Scheffold A; Lechel A; Rudolph KL; Ferger B
    Neuroreport; 2014 Mar; 25(5):335-9. PubMed ID: 24525820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H; Araki T; Nagasawa H; Itoyama Y
    Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse.
    Weihmuller FB; Bruno JP; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1990 May; 180(2-3):369-72. PubMed ID: 2365010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
    Xu CL; Qu R; Zhang J; Li LF; Ma SP
    Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circling behavior in old rats after unilateral intranigral injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lange KW
    Life Sci; 1989; 45(18):1709-14. PubMed ID: 2531261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
    Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T
    Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.
    Sonsalla PK; Heikkila RE
    Eur J Pharmacol; 1986 Oct; 129(3):339-45. PubMed ID: 3490988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
    Muroyama A; Inaka M; Matsushima H; Sugino H; Marunaka Y; Mitsumoto Y
    Neurosci Res; 2009 Jan; 63(1):72-5. PubMed ID: 18977253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.
    Hofele K; Sedelis M; Auburger GW; Morgan S; Huston JP; Schwarting RK
    Exp Neurol; 2001 Mar; 168(1):116-22. PubMed ID: 11170726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats.
    Perry JC; Da Cunha C; Anselmo-Franci J; Andreatini R; Miyoshi E; Tufik S; Vital MA
    Eur J Pharmacol; 2004 Jan; 484(2-3):225-33. PubMed ID: 14744607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.